title: Increased risk of rejection in cyclosporine monotherapy versus combined cyclosporine-steroid immunosuppression in young kidney recipients.
authors.affiliation: Renal Transplant Unit, Hospital Clínic i Provincial, Barcelona, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Oppenheimer
authors.forename: F
authors.initials: F
authors.lastname: Cofán
authors.forename: R
authors.initials: R
authors.lastname: Flores
authors.forename: B
authors.initials: B
authors.lastname: Pais
authors.forename: J
authors.initials: J
authors.lastname: Ochs
authors.forename: M J
authors.initials: MJ
authors.lastname: Ricart
authors.forename: J
authors.initials: J
authors.lastname: Vilardell
authors.forename: J M
authors.initials: JM
authors.lastname: Campistol
authors.forename: J V
authors.initials: JV
authors.lastname: Torregrosa
mesh_terms: D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors
chemical_list: D016572:Cyclosporine; D011241:Prednisone